Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Recurrent Pleomorphic Myxoid Liposarcoma in a Patient With Li-Fraumeni Syndrome.

Zare SY, Leivo M, Fadare O.

Int J Surg Pathol. 2019 Sep 27:1066896919878804. doi: 10.1177/1066896919878804. [Epub ahead of print]

PMID:
31559875
2.

Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.

Fashedemi Y, Coutts M, Wise O, Bonhomme B, Baker G, Kelly PJ, Soubeyran I, Catherwood MA, Croce S, McCluggage WG.

Am J Surg Pathol. 2019 Sep;43(9):1229-1238. doi: 10.1097/PAS.0000000000001296.

PMID:
31162286
3.

Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.

Necchi A, Bratslavsky G, Chung J, Millis S, Gay LM, Ali SM, Ross JS.

Oncologist. 2019 Apr;24(4):e142-e145. doi: 10.1634/theoncologist.2018-0430. Epub 2019 Jan 18.

PMID:
30659078
4.

Profiles of genomic alterations in primary esophageal follicular dendritic cell sarcoma: A case report.

Ren W, Sun Q, Wu PY, Huang B, Yang J, Yan J, Liu BR.

Medicine (Baltimore). 2018 Nov;97(48):e13413. doi: 10.1097/MD.0000000000013413.

5.

Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.

Naesens L, Devos H, Nollet F, Michaux L, Selleslag D.

Acta Haematol. 2018;140(2):97-104. doi: 10.1159/000491596. Epub 2018 Sep 18.

PMID:
30227397
6.

A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition.

Mathias MD, Ortiz MV, Magnan H, Ambati SR, Slotkin EK, Chou AJ, Walsh MF, Offit K, Moskowitz C, Kentsis A, Wexler LH.

Biomark Res. 2017 Feb 8;5:7. doi: 10.1186/s40364-017-0086-7. eCollection 2017.

7.

Genomic evolution and chemoresistance in germ-cell tumours.

Taylor-Weiner A, Zack T, O'Donnell E, Guerriero JL, Bernard B, Reddy A, Han GC, AlDubayan S, Amin-Mansour A, Schumacher SE, Litchfield K, Turnbull C, Gabriel S, Beroukhim R, Getz G, Carter SL, Hirsch MS, Letai A, Sweeney C, Van Allen EM.

Nature. 2016 Nov 30;540(7631):114-118. doi: 10.1038/nature20596.

8.

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

Bagrodia A, Lee BH, Lee W, Cha EK, Sfakianos JP, Iyer G, Pietzak EJ, Gao SP, Zabor EC, Ostrovnaya I, Kaffenberger SD, Syed A, Arcila ME, Chaganti RS, Kundra R, Eng J, Hreiki J, Vacic V, Arora K, Oschwald DM, Berger MF, Bajorin DF, Bains MS, Schultz N, Reuter VE, Sheinfeld J, Bosl GJ, Al-Ahmadie HA, Solit DB, Feldman DR.

J Clin Oncol. 2016 Nov 20;34(33):4000-4007. doi: 10.1200/JCO.2016.68.7798. Epub 2016 Sep 30.

9.

A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia.

Lu C, Riedell P, Miller CA, Hagemann IS, Westervelt P, Ozenberger BA, O'Laughlin M, Magrini V, Demeter RT, Duncavage EJ, Griffith M, Griffith OL, Wartman LD.

Cold Spring Harb Mol Case Stud. 2016 Jan;2(1):a000687. doi: 10.1101/mcs.a000687.

10.

Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent.

Leonard JT, Raess PW, Dunlap J, Hayes-Lattin B, Tyner JW, Traer E.

J Hematol Oncol. 2016 Mar 31;9:31. doi: 10.1186/s13045-016-0258-1.

11.

Targetable genetic features of primary testicular and primary central nervous system lymphomas.

Chapuy B, Roemer MG, Stewart C, Tan Y, Abo RP, Zhang L, Dunford AJ, Meredith DM, Thorner AR, Jordanova ES, Liu G, Feuerhake F, Ducar MD, Illerhaus G, Gusenleitner D, Linden EA, Sun HH, Homer H, Aono M, Pinkus GS, Ligon AH, Ligon KL, Ferry JA, Freeman GJ, van Hummelen P, Golub TR, Getz G, Rodig SJ, de Jong D, Monti S, Shipp MA.

Blood. 2016 Feb 18;127(7):869-81. doi: 10.1182/blood-2015-10-673236. Epub 2015 Dec 23.

12.

Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor.

Oshrine BR, Olsen MN, Heneghan M, Wertheim G, Daber R, Wilmoth DM, Biegel JA, Pawel B, Aplenc R, King RL.

Cancer Genet. 2014 Apr;207(4):153-9. doi: 10.1016/j.cancergen.2014.03.009. Epub 2014 Apr 5.

PMID:
24831771
13.

[Bendamustine-rituximab therapy is effective for transformed follicular lymphoma with significant expression of p53].

Kuroda H, Jomen W, Miura S, Arihara Y, Yamada M, Hirako T, Abe T, Sakurai T, Fujii S, Maeda M, Fujita M, Nagashima K, Okagawa Y, Hoki T, Kato J.

Gan To Kagaku Ryoho. 2013 Aug;40(8):1055-8. Japanese.

PMID:
23986050
14.

Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression.

Luo CQ, Yeung SC, Liu ZG, Meng J, Zhong FT, Cheng C.

Cancer Biol Ther. 2012 Dec;13(14):1384-9. doi: 10.4161/cbt.22253. Epub 2012 Sep 17.

15.

Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.

Skálová A, Sima R, Vanecek T, Muller S, Korabecna M, Nemcova J, Elmberger G, Leivo I, Passador-Santos F, Walter J, Rousarova M, Jedlickova K, Curik R, Geierova M, Michal M.

Am J Surg Pathol. 2009 Aug;33(8):1137-45. doi: 10.1097/PAS.0b013e3181a38e1c.

PMID:
19461506

Supplemental Content

Loading ...
Support Center